Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TS Communications Group was a specialized healthcare and life sciences communications agency that provided strategic public relations, investor relations, and patient recruitment services. Operating primarily as an affiliate of Richard Lewis Communications (RLC), the firm supported biotechnology and pharmaceutical companies in managing corporate positioning, clinical trial visibility, and financial communications. The group represented notable clients such as Cyclacel Pharmaceuticals, Aphton Corporation, and Lentigen Corporation, assisting with high-stakes announcements including Phase III trial results and corporate acquisitions. The firm's leadership later transitioned to other specialized life science communications ventures, such as Tiberend Strategic Advisors, continuing their work in the biopharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TS Communications Group.